Posted Sep. 10, 2013 at 7:13 a.m.

Premium Lock Biogen, which has big RTP operation, signs $100M drug deal

Published: 2013-09-10 07:13:09
Updated: 2013-09-10 07:13:09

Biogen's RTP plant Biogen's RTP plant

Biogen Idec, the maker of the multiple sclerosis pill Tecfidera, expanded its partnership with Isis Pharmaceuticals Inc. in a deal worth at least $100 million to develop drugs for neurological disorders....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll